DRREDDY — Dr Reddy's Laboratories Balance Sheet
0.000.00%
- IN₹997.32bn
- IN₹983.35bn
- IN₹280.11bn
- 78
- 22
- 69
- 61
Annual balance sheet for Dr Reddy's Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 25,616 | 34,387 | 44,207 | 61,642 | 81,313 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 60,875 | 61,337 | 78,083 | 87,993 | 98,831 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 125,991 | 145,503 | 177,823 | 204,255 | 248,053 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 52,143 | 56,861 | 61,665 | 66,294 | 75,997 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 232,253 | 266,168 | 297,469 | 322,851 | 388,638 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 72,141 | 81,038 | 97,658 | 85,721 | 95,880 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 76,265 | 89,751 | 105,345 | 89,990 | 106,090 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 155,988 | 176,417 | 192,124 | 232,861 | 282,548 |
Total Liabilities & Shareholders' Equity | 232,253 | 266,168 | 297,469 | 322,851 | 388,638 |
Total Common Shares Outstanding |